Advisor Group Inc. raised its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 41.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 86,420 shares of the pharmacy operator’s stock after purchasing an additional 25,527 shares during the period. Advisor Group Inc.’s holdings in Walgreens Boots Alliance were worth $6,278,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of the business. Pathstone Family Office LLC lifted its position in Walgreens Boots Alliance by 226.6% during the second quarter. Pathstone Family Office LLC now owns 1,179 shares of the pharmacy operator’s stock valued at $1,969,000 after purchasing an additional 818 shares in the last quarter. Westside Investment Management Inc. raised its holdings in Walgreens Boots Alliance by 10.4% during the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after acquiring an additional 125 shares during the period. Zions Bancorporation increased its holdings in shares of Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 1,239 shares during the last quarter. Bristlecone Advisors LLC bought a new stake in shares of Walgreens Boots Alliance in the third quarter worth about $135,000. Finally, Trustcore Financial Services LLC bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth about $155,000. Institutional investors and hedge funds own 60.94% of the company’s stock.
In other news, insider Stefano Pessina purchased 98,858 shares of the business’s stock in a transaction dated Monday, January 15th. The stock was acquired at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 14.80% of the stock is currently owned by corporate insiders.
Walgreens Boots Alliance stock traded down $2.37 during midday trading on Monday, reaching $63.10. The company had a trading volume of 7,682,891 shares, compared to its average volume of 5,869,593. The firm has a market capitalization of $64,924.35, a PE ratio of 12.37, a P/E/G ratio of 1.05 and a beta of 1.16. Walgreens Boots Alliance Inc has a 12-month low of $62.48 and a 12-month high of $87.79. The company has a current ratio of 0.90, a quick ratio of 0.45 and a debt-to-equity ratio of 0.44.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.55 by $0.18. The firm had revenue of $33.02 billion for the quarter, compared to analyst estimates of $32.20 billion. Walgreens Boots Alliance had a net margin of 3.33% and a return on equity of 20.38%. Walgreens Boots Alliance’s quarterly revenue was up 12.1% compared to the same quarter last year. During the same period last year, the company posted $1.36 EPS. sell-side analysts predict that Walgreens Boots Alliance Inc will post 5.93 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 12th. Shareholders of record on Thursday, February 15th were issued a $0.40 dividend. The ex-dividend date was Wednesday, February 14th. This represents a $1.60 dividend on an annualized basis and a yield of 2.54%. Walgreens Boots Alliance’s payout ratio is 31.37%.
WBA has been the subject of several recent analyst reports. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Thursday. Scotiabank dropped their target price on Walgreens Boots Alliance from $93.00 to $91.00 and set an “outperform” rating for the company in a research report on Monday. Royal Bank of Canada set a $88.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Wednesday, March 28th. They noted that the move was a valuation call. Pivotal Research set a $70.00 price target on Walgreens Boots Alliance and gave the company a “hold” rating in a report on Thursday. Finally, Needham & Company LLC restated a “buy” rating and set a $88.00 target price (up previously from $86.00) on shares of Walgreens Boots Alliance in a report on Wednesday, January 10th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $84.52.
WARNING: This article was first published by Enterprise Leader and is the property of of Enterprise Leader. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://theenterpriseleader.com/2018/04/02/advisor-group-inc-has-6-28-million-holdings-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.